AD
Adagene Inc.
ADAG · NASDAQ
$3.20 +0.16% (+$0.01)
1M -8.83%
Market Cap $120.5M
P/E Ratio -
Div. Yield -
ROE 30.65%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
5/9Valuation
30 /100
Expensive P/B 3.41x
P/S 15.71x
PEG N/A
Growth
0 /100
Declining Book val. growth 24.79%
Rev. growth 6.19%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 204.34%
Op. margin 279.48%
Gross margin 100.00%
Quality
1 /100
Poor Asset turnover 0.10x
ROA 22.50%
ROIC 36.25%
Debt
69 /100
Low Current ratio 3.07x
Int. coverage -37.67x
Debt/Equity 0.18x
Stability
24 /100
Unstable Profitable years 0
EPS volatility 81.81%
Beta 0.56x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ADAG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Luo
Employees
128
Headquarters
Suzhou
Prihajajoči dogodki
31 MAR.
Earnings
Upcoming earnings report